Tower Research Capital (TRC)’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $244K | Buy |
4,788
+3,810
| +390% | +$194K | 0.01% | 1595 |
|
|
2025
Q1 | $44.1K | Sell |
978
-4,134
| -81% | -$186K | ﹤0.01% | 2314 |
|
|
2024
Q4 | $211K | Buy |
5,112
+3,694
| +261% | +$153K | ﹤0.01% | 1682 |
|
|
2024
Q3 | $55.3K | Sell |
1,418
-5,779
| -80% | -$225K | ﹤0.01% | 2668 |
|
|
2024
Q2 | $246K | Buy |
7,197
+3,844
| +115% | +$131K | ﹤0.01% | 1914 |
|
|
2024
Q1 | $84.2K | Sell |
3,353
-882
| -21% | -$22.2K | ﹤0.01% | 1924 |
|
|
2023
Q4 | $125K | Buy |
4,235
+2,642
| +166% | +$78K | ﹤0.01% | 2466 |
|
|
2023
Q3 | $50.3K | Sell |
1,593
-253
| -14% | -$8K | ﹤0.01% | 2543 |
|
|
2023
Q2 | $47.8K | Buy |
1,846
+1,202
| +187% | +$31.1K | ﹤0.01% | 2601 |
|
|
2023
Q1 | $15K | Sell |
644
-1,685
| -72% | -$39.2K | ﹤0.01% | 3796 |
|
|
2022
Q4 | $45K | Buy |
2,329
+119
| +5% | +$2.3K | ﹤0.01% | 2433 |
|
|
2022
Q3 | $46K | Sell |
2,210
-593
| -21% | -$12.3K | ﹤0.01% | 3237 |
|
|
2022
Q2 | $55K | Sell |
2,803
-2,876
| -51% | -$56.4K | ﹤0.01% | 2798 |
|
|
2022
Q1 | $125K | Buy |
5,679
+1,611
| +40% | +$35.5K | ﹤0.01% | 2048 |
|
|
2021
Q4 | $65K | Buy |
4,068
+3,486
| +599% | +$55.7K | ﹤0.01% | 2559 |
|
|
2021
Q3 | $12K | Sell |
582
-63
| -10% | -$1.3K | ﹤0.01% | 4158 |
|
|
2021
Q2 | $11K | Buy |
645
+8
| +1% | +$136 | ﹤0.01% | 4329 |
|
|
2021
Q1 | $13K | Sell |
637
-4,920
| -89% | -$100K | ﹤0.01% | 4207 |
|
|
2020
Q4 | $97K | Sell |
5,557
-979
| -15% | -$17.1K | ﹤0.01% | 2383 |
|
|
2020
Q3 | $126K | Buy |
6,536
+5,376
| +463% | +$104K | ﹤0.01% | 2954 |
|
|
2020
Q2 | $23K | Buy |
+1,160
| New | +$23K | ﹤0.01% | 3605 |
|
|
2019
Q4 | – | Sell |
-886
| Closed | -$9K | – | 4057 |
|
|
2019
Q3 | $9K | Buy |
+886
| New | +$9K | ﹤0.01% | 3001 |
|